How many institutions held GLPG - Lakefront Biotherapeutics NV - Ordinary shares, no par value in Q2 2021?

99 institutional investors reported GLPG - Lakefront Biotherapeutics NV - Ordinary shares, no par value for Q2 2021. Use the holders table for investor-level position and value details.

Lakefront Biotherapeutics NV - Ordinary shares, no par value (GLPG)

Q: What does CUSIP 36315X101 represent in this 13F holders report?

CUSIP 36315X101 is the security identifier for GLPG - Lakefront Biotherapeutics NV - Ordinary shares, no par value used to aggregate holder disclosures.

CUSIP: 36315X101

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class: Equity / Ordinary shares, no par value
Shares outstanding: 66,186,595
Total 13F shares: 7,506,771
Share change: +943,356
Total reported value: $517,197,342
Put/Call ratio: 286%
Price per share: $68.89
Number of holders: 99
Value change: +$62,993,693
Number of buys: 44
Number of sells: 71

Quarterly Holders Quick Answers

What is CUSIP 36315X101?
CUSIP 36315X101 identifies GLPG - Lakefront Biotherapeutics NV - Ordinary shares, no par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2021
Previous quarter: Q1 2021

Recent filing periods for CUSIP 36315X101:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of GLPG - Lakefront Biotherapeutics NV - Ordinary shares, no par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Capital International Investors	13F	Company	2.8%	1,834,743	$141,184,000	—	31 Mar 2021	13F
FMR LLC	13F	Company	0.91%	604,523	$46,603,000	—	31 Mar 2021	13F
Point72 Asset Management, L.P.	13F	Company	0.7%	465,478	$35,884,000	—	31 Mar 2021	13F
CITADEL ADVISORS LLC	13F	Company	0.44%	291,667	$22,485,000	—	31 Mar 2021	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.39%	260,087	$20,050,000	—	31 Mar 2021	13F
ORBIMED ADVISORS LLC	13F	Company	0.35%	230,905	$17,800,000	—	31 Mar 2021	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.3%	201,867	$15,562,000	—	31 Mar 2021	13F
Ikarian Capital, LLC	13F	Company	0.3%	200,000	$15,513,000	—	31 Mar 2021	13F
MORGAN STANLEY	13F	Company	0.25%	166,062	$12,801,000	—	31 Mar 2021	13F
FEDERATED HERMES, INC.	13F	Company	0.25%	165,000	$12,720,000	—	31 Mar 2021	13F
Rock Springs Capital Management LP	13F	Company	0.25%	165,000	$12,720,000	—	31 Mar 2021	13F
Parallax Volatility Advisers, L.P.	13F	Company	0.24%	161,585	$12,457,000	—	31 Mar 2021	13F
Aquilo Capital Management, LLC	13F	Company	0.18%	116,723	$8,998,000	—	31 Mar 2021	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.17%	111,258	$8,577,000	—	31 Mar 2021	13F
CANADA PENSION PLAN INVESTMENT BOARD	13F	Company	0.16%	107,500	$8,287,000	—	31 Mar 2021	13F
VOLORIDGE INVESTMENT MANAGEMENT, LLC	13F	Company	0.14%	91,428	$7,048,000	—	31 Mar 2021	13F
Sessa Capital IM, L.P.	13F	Company	0.12%	82,000	$6,321,000	—	31 Mar 2021	13F
Schonfeld Strategic Advisors LLC	13F	Company	0.12%	76,875	$5,926,000	—	31 Mar 2021	13F
DAFNA Capital Management LLC	13F	Company	0.11%	75,175	$5,795,000	—	31 Mar 2021	13F
Caption Management, LLC	13F	Company	0.11%	71,567	$5,517,000	—	31 Mar 2021	13F
NORGES BANK	13F	Company	0.11%	70,000	$5,396,000	—	31 Mar 2021	13F
BALYASNY ASSET MANAGEMENT L.P.	13F	Company	0.1%	68,129	$5,252,000	—	31 Mar 2021	13F
Prosight Management, LP	13F	Company	0.1%	66,419	$5,120,000	—	31 Mar 2021	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.1%	63,614	$4,904,000	—	31 Mar 2021	13F
BlackRock Finance, Inc.	13F	Company	0.09%	61,162	$4,715,000	—	31 Mar 2021	13F
Hudson Bay Capital Management LP	13F	Company	0.09%	57,500	$4,433,000	—	31 Mar 2021	13F
GROUP ONE TRADING LLC	13F	Company	0.06%	39,536	$3,048,000	—	31 Mar 2021	13F
ROYAL BANK OF CANADA	13F	Company	0.06%	37,445	$2,887,000	—	31 Mar 2021	13F
Henry James International Management Inc.	13F	Company	0.05%	35,370	$2,727,000	—	31 Mar 2021	13F
HealthCor Management, L.P.	13F	Company	0.05%	34,260	$2,641,000	—	31 Mar 2021	13F
Ergoteles LLC	13F	Company	0.05%	32,654	$2,517,000	—	31 Mar 2021	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.04%	28,799	$2,220,000	—	31 Mar 2021	13F
ENVESTNET ASSET MANAGEMENT INC	13F	Company	0.04%	24,893	$1,919,000	—	31 Mar 2021	13F
BOOTHBAY FUND MANAGEMENT, LLC	13F	Company	0.04%	24,674	$1,902,000	—	31 Mar 2021	13F
Susquehanna International Securities, Ltd.	13F	Company	0.03%	21,700	$1,673,000	—	31 Mar 2021	13F
Freedom Investment Management, Inc.	13F	Company	0.03%	20,770	$1,601,000	—	31 Mar 2021	13F
Capital International, Inc./CA/	13F	Company	0.03%	20,246	$1,561,000	—	31 Mar 2021	13F
Cutler Group LLC / CA	13F	Company	0.03%	19,650	$1,514,000	—	31 Mar 2021	13F
CAPITAL FUND MANAGEMENT S.A.	13F	Company	0.03%	19,223	$1,481,901	—	31 Mar 2021	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.03%	18,051	$1,391,000	—	31 Mar 2021	13F
NOMURA ASSET MANAGEMENT CO LTD	13F	Company	0.03%	17,200	$1,325,948	—	31 Mar 2021	13F
AlphaCentric Advisors LLC	13F	Company	0.03%	17,000	$1,311,000	—	31 Mar 2021	13F
JANE STREET GROUP, LLC	13F	Company	0.03%	16,941	$1,306,000	—	31 Mar 2021	13F
Cubist Systematic Strategies, LLC	13F	Company	0.02%	16,451	$1,268,000	—	31 Mar 2021	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0.02%	14,087	$1,086,000	—	31 Mar 2021	13F
US BANCORP \DE\	13F	Company	0.02%	14,056	$1,083,000	—	31 Mar 2021	13F
STIFEL FINANCIAL CORP	13F	Company	0.02%	12,560	$968,000	—	31 Mar 2021	13F
Affinity Asset Advisors, LLC	13F	Company	0.02%	12,500	$964,000	—	31 Mar 2021	13F
HRT FINANCIAL LP	13F	Company	0.02%	11,494	$886,000	—	31 Mar 2021	13F
BAKER BROS. ADVISORS LP	13F	Company	0.02%	11,180	$862,000	—	31 Mar 2021	13F

Institutional Holders of Lakefront Biotherapeutics NV - Ordinary shares, no par value (GLPG) as of Q2 2021

As of 30 Jun 2021, Lakefront Biotherapeutics NV - Ordinary shares, no par value (GLPG) was held by 99 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,506,771 shares. The largest 10 holders included Capital International Investors, Point72 Asset Management, L.P., DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), FMR LLC, CITADEL ADVISORS LLC, BlackRock Inc., Parallax Volatility Advisers, L.P., ORBIMED ADVISORS LLC, Ikarian Capital, LLC, and MORGAN STANLEY. This page lists 99 institutional shareholders reporting positions in this security for the Q2 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2021 vs Q1 2021 Across Filers

Q1 2021 holders

123

Q2 2021 holders

Holder diff

-24

Investor	Q1 2021 Shares	Q2 2021 Shares	Share Diff	Share Chg %	Q1 2021 Value $	Q2 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.